Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05884970Phase 3Unknown
Phase 3 trial of salbutamol in asthma (5 arms), sponsored by Canisius-Wilhelmina Hospital. Primary endpoint: Forced Expiratory Volume in 1 second after 100ug salbutamol. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05884970.